News
- Author:
- Neil Osterweil
Publish date: April 8, 2015
Key clinical point: A surgeon-led clinical documentation program can increase revenue by demonstrating case-mix severity.
Major finding: An audit ...
News
- Author:
- Neil Osterweil
Publish date: April 8, 2015
Key clinical point: The bedside risk scale can be used in patient counseling prior to surgery for gastric malignancies.
Major finding: Patients wi...
News
- Author:
- Neil Osterweil
Publish date: April 6, 2015
Key clinical point: Palliative surgery in patients with advanced cancers can relieve pain with minimal morbidity.
Major finding: Pain scores impro...
News
- Author:
- Neil Osterweil
Publish date: March 5, 2015
Key clinical point: Patients with metastatic renal cell carcinoma and high BMI have better outcomes than patients with low or normal BMI.
Major fi...
News
- Author:
- Neil Osterweil
Publish date: March 4, 2015
Key clinical point: A combination antiangiogenesis regimen appears to have good activity in heavily pretreated patients with advanced metastatic r...
News
- Author:
- Neil Osterweil
Publish date: March 3, 2015
Key clinical point: Neoadjuvant chemotherapy is preferred, but adjuvant chemotherapy improves overall survival of locally advanced bladder cancer....
News
- Author:
- Neil Osterweil
Publish date: March 3, 2015
Key clinical point:.
News
- Author:
- Neil Osterweil
Publish date: March 2, 2015
Key clinical point: Following BCG induction with sunitinib improves 3 month response rates in non–muscle invasive bladder cancer (NMIBC) ove...
News
- Author:
- Neil Osterweil
Publish date: March 2, 2015
Key clinical point: Gene expression profiling can predict clinical responses to neoadjuvant chemotherapy for bladder cancer.
Major finding:A progn...
News
- Author:
- Neil Osterweil
Publish date: February 27, 2015
Key clinical point: The AR-V7 variant appears to confer resistance to abiraterone and enzalutamide, but not to taxanes.
Major finding: There was n...
News
- Author:
- Neil Osterweil
Publish date: February 27, 2015
Key clinical point: A history of testicular cancer appears to be a risk factor for intermediate- to high-risk prostate cancer.
News
- Author:
- Neil Osterweil
Publish date: February 26, 2015
Key clinical point: Bicalutamide improved overall survival in men with locally advanced but not organ-confined prostate cancer.
Major finding: Aft...
News
- Author:
- Neil Osterweil
Publish date: February 23, 2015
Key clinical point: Active surveillance may not be appropriate for management of intermediate-risk prostate cancer.
Major finding: Men with interm...
News
- Author:
- Neil Osterweil
Publish date: January 26, 2015
News
- Author:
- Neil Osterweil
Publish date: December 9, 2014
Key clinical point: Sotatercept is a first-in-its-class agent that stimulates erythropoiesis through a mechanism different from that of erythropoi...
